Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug approved in Canada for treating Attention-Deficit/Hyperactivity Disorder (ADHD) in youngsters and people. This functions as a prodrug, meaning https://vyvanse-shop-in-canada324469.p2blogs.com/41706615/vyvanse-in-the-nation-a-comprehensive-explanation